International cancer research collaborates with SURF Research Cloud to personalise cancer treatment

19.07.2022

The computational pathology research group of the Netherlands Cancer Institute (NKI) is on a mission to personalise cancer treatment by using the SURF Research Cloud. SURF is a collaborative organisation of Dutch educational and research institutions with several IT and cloud services. To personalise cancer treatment, the NKI’s motto is “the right treatment for the right person at the right time”. Their mission is to achieve international collaboration at large scale.

The NKI will create a space for sharing sensitive data

When working with sensitive data, it is vital that researchers ensure their research has an impact on society whilst to privacy regulations and FAIR data principles (findable, accessible, interoperable, and reusable). To achieve this,
the NKI will create a space for sharing data by collaborating with the Integraal Kankercentrum Nederland (IKNL) and the University of Helsinki. Together they will focus on improving treatments like immune therapy, targeted therapies, and chemotherapy. In the NKI’s research lifecycle patients' data is already being gathered according to a data management plan, and an institutional review board to review patients' data is already in place. For storing, using, and sharing of data like clinical data, pathological data, and genomical data, a total volume of about 250GB, SURF Research Cloud seems to be the fast and secure solution.

To learn more about the SURF Research Cloud and the Dutch-Finnish collaboration, watch the video presentation SURF gave at their Research Week earlier this year.

International cancer research collaborates with SURF Research Cloud to personalise cancer treatment
Image credit:
2022, SURF

For questions and comments, please visit our forum on Futurium.